The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - Shares of Aeterna Zentaris (NASDAQ:AEZS) are strong Thursday morning after a Buy initiation from Roth Capital with a $1.75 price target, more than double its … Continue Reading
Read nowLong Ideas - AVEO Pharmaceuticals (NASDAQ:AVEO) announced on Thursday morning that the company will be presenting new data for both of its lead candidates, tivozanib and ficlatuzumab, at … Continue Reading
Read nowQuick Picks - Delcath Systems (NASDAQ:DCTH) is trading with above-average volume for the second day in a row, but after gapping up 8% at the open, is giving … Continue Reading
Read nowLong Ideas - After a Buy rating from theStreet.com yesterday and a presentation Wednesday morning at the UBS Global Life Sciences conference, NPS Pharmaceuticals (NASDAQ:NPSP) gapped up 4% … Continue Reading
Read nowLong Ideas - After Bristol-Myers Squibb (NYSE:BMY) discontinued development of BMS-986094, once a promising nucleotide type drug for hepatitis C (HCV), in August, funds invested in this drug … Continue Reading
Read nowQuick Picks - Spectrum Pharmaceuticals (NASDAQ:SPPI) moves another cancer treatment further along the pipeline on Wednesday with the initiation of a Phase III trial of Zevalin as a … Continue Reading
Read nowLong Ideas - On Tuesday morning, Navidea Biopharmaceuticals (NASDAQ:NAVB) announced that it commenced enrollment of a Phase II trial for its radiopharmaceutical agent, NAV4694, which is being tested … Continue Reading
Read now
